The Handoff is a weekly roundup of neurology news covering various developments in subspecialties, as well as pharmaceutical and association and society news. Keep your finger on the pulse of neurology with The Handoff.

– Impax Laboratories issued a voluntary recall of a single lot of lamotrigine due to 100 mg blister packs being packaged in 200 mg containers. The lot was distributed to wholesalers and retail pharmacies from June through August. 

Continue Reading

– Gene Wilder’s death from “complications of Alzheimer’s” may serve as the stigma breakthrough the neurodegenerative disease desperately needs in order to raise awareness.

– Child neurologists and neurobehavioral specialists are fighting an uphill battle against dwindling staff and dissatisfaction with compensation and benefits. 

– A report from the CDC suggests that illegal fentanyl is behind a near 175% increase in opioid-related deaths in 1 year in some “high-burden” states.

– A quarrel between Georgetown researchers and the Micheal J. Fox Foundation may put a pivotal Parkinson’s disease clinical trial on hold for another year. 

– The US FDA is calling for black box warnings to be added to opioid analgesics, opioid cough products, and benzodiazepines to increase awareness of risk of death with combined use. 

– Memorial Hermann Texas Medical Center was granted nearly $7 million to expand its study of the Mobile Stroke Unit program across the US. 

– A review published in Mayo Clinic Proceedings found that complimentary health approaches — such as yoga, tai chi, and acupuncture — are effective in managing pain conditions. 

– With children across the US headed back to school — and school sports — this week, Mayo Clinic offers up some insight on the utility of concussion screenings and why it’s important to develop a baseline for young athletes. Watch the interview with sports medicine specialist Dr Jennifer Maynard below.